Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions

Knee Joint Pain

Interventions

DRUG

PlexoZome® Levagen® topical spray solution

PlexoZome® Levagen® topical spray solution 10mg/g providing 1.8mg active per pump

DRUG

Placebo topical spray solution

Placebo topical spray solution topical spray solution 0mg/g providing 0mg active per pump

Trial Locations (1)

RDC Clinical Pty Ltd, Brisbane

All Listed Sponsors

lead

RDC Clinical Pty Ltd

INDUSTRY

NCT06351917 - Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain | Biotech Hunter | Biotech Hunter